Utility of para-aminosalicylic acid in drug-resistant tuberculosis: Should it be classified as Group D3 or Group C?

BACKGROUND: The World Health Organization drug-resistant tuberculosis (DR-TB) 2016 guidelines reclassified para-aminosalicylic acid (PAS) as Group D3 “add-on” drug. We studied our DR-TB data wherein PAS was widely and preferably used as a substitute in the standardized regimen in varied situations a...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Unnati, Joshi, Jyotsna M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219125/
https://www.ncbi.nlm.nih.gov/pubmed/30381558
http://dx.doi.org/10.4103/lungindia.lungindia_141_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219125/
https://www.ncbi.nlm.nih.gov/pubmed/30381558
http://dx.doi.org/10.4103/lungindia.lungindia_141_18

Ejemplares similares